Tide Chem specializes in the fields of mono-molecule polyethylene glycol (small-molecule PEG), peptide drugs, and small nucleic acid drugs, integrating R&D, production, and sales. It is a trusted partner and important contributor to the global pharmaceutical and life sciences industry. Tide Chem is committed to providing exceptional one-stop CDMO services and continuously promoting global pharmaceutical and healthcare innovation. 

Tide Chem has established a long-acting modifier platform for peptide drugs, offering hundreds of structurally diverse long-acting side chain molecules, as well as high-quality side chain design services, quality research, and CDE submission document preparation support. Its long-acting side chain technology can be widely applied in the fields of rare diseases, tumors, metabolism and endocrinology, and cardiovascular diseases, effectively extending the half-life of drugs and improving patient compliance. Tide Chem has developed and manufactured a wide range of innovative, high-quality long-acting peptide side-chain products for over 200 companies worldwide, including the alkane, MIPA, and cholesterol series. These molecular building blocks help customers quickly achieve the screening and development of innovative peptide drugs. Additionally, the company possesses mature production processes for hundreds of products, including protected amino acids, short peptides, pseudo-peptides, and peptide fragments, enabling it to provide customized supply services for global peptide drug R&D. The relevant technologies have reached internationally advanced levels.

Tide Chem continues to focus on the field of small molecule PEG derivatives, applying mono molecular weight PEG to drug delivery systems and establishing mono molecular weight liposome building blocks for the administration of SiRNA nucleic acid drugs, significantly improving drug stability and extending half-life. This type of liposome product can effectively improve product quality, reduce side effects caused by impurities, and reduce the complexity of impurity research.

In the field of upstream core raw materials for nucleic acid drugs, Tide Chem has been focusing on the R&D, and production of key raw materials for small nucleic acid drugs for many years, including nucleotide monomers, nucleoside monomers, phosphoramidite monomers, and delivery systems. The company provides cost-effective products and process routes, supporting production from milligram to kilogram scale, and fully meeting the R&D needs of customers at different stages.